CPMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CPMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cannapharmarx's change in inventory for the quarter that ended in Sep. 2024 was $-0.06 Mil. It means Cannapharmarx's inventory increased by $0.06 Mil from Jun. 2024 to Sep. 2024 .
Cannapharmarx's change in inventory for the fiscal year that ended in Dec. 2023 was $-1.13 Mil. It means Cannapharmarx's inventory increased by $1.13 Mil from Dec. 2022 to Dec. 2023 .
Cannapharmarx's Total Inventories for the quarter that ended in Sep. 2024 was $1.22 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cannapharmarx's Days Inventory for the quarter that ended in Sep. 2024 was 168.16.
Inventory Turnover measures how fast the company turns over its inventory within a year. Cannapharmarx's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cannapharmarx's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 3.95.
The historical data trend for Cannapharmarx's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannapharmarx Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Change In Inventory | Get a 7-Day Free Trial | - | - | - | - | -1.13 |
Cannapharmarx Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Change In Inventory | Get a 7-Day Free Trial | - | - | -0.03 | -0.53 | -0.06 |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannapharmarx (OTCPK:CPMD) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cannapharmarx's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 1.231 | / | 0.668 | * | 365 / 4 | |
= | 168.16 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cannapharmarx's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.668 | / | 1.231 | |
= | 0.54 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cannapharmarx's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 1.231 | / | 0.312 | |
= | 3.95 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Cannapharmarx's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Anthony Michael Panek | director | 95 SOUTH STATE STREET, SUITE 2300, SALT LAKE CITY UT 84111 |
Dominic Colvin | director, officer: Chief Executive Officer | C/O CANNAPHARMARX, INC., 2 PARK PLAZA, SUITE 1200-B, IRVINE CA 92614 |
John Hamilton Cassels | officer: Chief Financial Officer | SUITE 500, 209 8TH AVENUE SW, CALGARY A0 T2P 1B8 |
Richard Dale Orman | director | 302, 3204 RIDEAU PLACE SW, CALGARY A0 T2S1Z2 |
Andrew Clifford Steedman | officer: Chief Operating Officer | 1131 RIVERDALE AVE SW, CALGARY A0 T2S 0Y9 |
Marc R Branson | director | 977 KEITH ROAD, WEST VANCOUVER A1 V7T 1M6 |
Gary J Herick | 10 percent owner | 7609 RALSTON ROAD, ARVADA CO 80002 |
James F Samuelson | director | PO BOX 22, NEWPORT BEACH CA 92662 |
Matthew Nicosia | director, 10 percent owner | 2 PARK PLAZA, SUITE 400, IRVINE CA 92614 |
Robert M Liess | director | 2602 W. SAM ALLEN RD., PLANT CITY FL 33565 |
Mathew D Sherwood | director | P.O. BOX 4375, DILLON CO 80435 |
James E Smeeding | director | 4029 GILBERT AVENUE, DALLAS TX 75219 |
Elie M Khalife | director | 9447 E. CROSS CREEK STREET, WICHITA KS 67206 |
Steven J Rule | director | C/O CANNAPHARMARX, INC., ONE COLLINS DRIVE, SUITE 100, CARNEYS POINT NJ 08069 |
Alexander R Giaquinto | director | 120 MOUNTAIN VIEW BOULEVARD, BASKING RIDGE NJ 07920 |
From GuruFocus
By ACCESSWIRE • 06-23-2023
By ACCESSWIRE ACCESSWIRE • 12-19-2022
By ACCESSWIRE • 02-16-2024
By ACCESSWIRE ACCESSWIRE • 03-30-2023
By ACCESSWIRE ACCESSWIRE • 12-21-2022
By ACCESSWIRE ACCESSWIRE • 02-08-2022
By ACCESSWIRE • 06-28-2024
By ACCESSWIRE • 11-05-2024
By ACCESSWIRE • 08-25-2023
By ACCESSWIRE • 05-20-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.